FIMG
TEVA icon

Financial & Investment Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Financial & Investment Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-24,138
Closed -$967K – 124
2013
Q4 		$967K Buy
24,138
+17,816
+282% +$702K 0.3% 69
2013
Q3 		$239K Buy
6,322
+101
+2% +$3.94K 0.09% 73
2013
Q2 		$244K Buy
+6,221
New +$242K 0.14% 56

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Financial & Investment Management Group's TEVA Position: Q1 2014 in Review

Financial & Investment Management Group sold out of Teva Pharmaceuticals (TEVA) in Q1 2014, closing a stake of 24,138 shares — an estimated $967K sold.

Financial & Investment Management Group first reported a position in TEVA in Q2 2013 and held it in 3 quarters. The position peaked at $967K in Q4 2013. 771 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

  • Financial & Investment Management Group reported no remaining Teva Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Financial & Investment Management Group sold 24,138 Teva Pharmaceuticals shares in Q1 2014, an estimated $967K.
  • Financial & Investment Management Group first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Financial & Investment Management Group's Teva Pharmaceuticals position peaked at $967K in Q4 2013.
  • 771 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2014.

Based on Financial & Investment Management Group's 13F filing for Q1 2014, filed 17 Apr 2014.